Van Eck Associates Corp Cooper Companies, Inc. Transaction History

Van Eck Associates Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 03, 2022	SELL	$301.4 - $428.42 $2.18 Million - $3.1 Million	-7,247 Reduced 73.25%	2,646 $829,000
Q1 2022 May 10, 2022	BUY	$379.46 - $424.54 $359,348 - $402,039	947 Added 10.59%	9,893 $4.13 Million
Q4 2021 Jan 26, 2022	BUY	$373.53 - $434.12 $391,459 - $454,957	1,048 Added 13.27%	8,946 $3.75 Million
Q3 2021 Nov 03, 2021	BUY	$396.76 - $455.92 $406,679 - $467,318	1,025 Added 14.91%	7,898 $3.26 Million
Q2 2021 Aug 10, 2021	BUY	$372.36 - $412.07 $1.95 Million - $2.15 Million	5,224 Added 316.8%	6,873 $2.72 Million
Q1 2021 May 13, 2021	BUY	$357.26 - $392.57 $589,121 - $647,347	1,649 New	1,649 $633,000

1.59M

Ticker COO
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 49,346,000
Market Cap $4.92B
Description
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses corr...

Get notified when there are updates to the investment portfolio of Van Eck Associates Corp, based on Form 13F filings with the SEC.

Stay updated on Van Eck Associates Corp with notifications on news.